
Indivior PLC Ordinary Shares
INDV
INDV: Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
moreShow INDV Financials
Recent trades of INDV by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by INDV's directors and management
Government lobbying spending instances
-
$290,000 Jul 20, 2023 Issue: Health Issues
New patents grants
Federal grants, loans, and purchases
Followers on INDV's company Twitter account
Number of mentions of INDV in WallStreetBets Daily Discussion
Recent insights relating to INDV
Recent picks made for INDV stock on CNBC
ETFs with the largest estimated holdings in INDV
Flights by private jets registered to INDV